The Second Gaddum Lecture: its origins and outcomes

@article{Bakhle2019TheSG,
  title={The Second Gaddum Lecture: its origins and outcomes},
  author={Y. Bakhle},
  journal={British Journal of Pharmacology},
  year={2019},
  volume={177},
  pages={969 - 977}
}
  • Y. Bakhle
  • Published 2019
  • Medicine
  • British Journal of Pharmacology
Fifty years ago, the BJP published the Second Gaddum Lecture, given by John Vane to the British Pharmacological Society. This article assesses the origins of the experiments described in the Lecture, linking them directly to Gaddum's use of bioassay, a defining feature of pharmacology. The outcomes of those experiments are also assessed, tracking those results that have survived the past five decades. Two of the major advances in cardiovascular medicine, the ACE inhibitors, as anti… Expand

References

SHOWING 1-10 OF 102 REFERENCES
The technique of superfusion
Jack Gaddum was one of the giants of pharmacology in the 1950's. Along with Harold Burn, George Brownlee, Willie Bain, A.D. MacDonald and Gladwin Buttle, he dominated meetings of the BritishExpand
Prostaglandins, bioassay and inflammation
  • R. Flower
  • Medicine, Chemistry
  • British journal of pharmacology
  • 2006
TLDR
This paper traces the development of the PG field, with particular emphasis on the skilful utilisation of the twin techniques of bioassay and analytical chemistry by U.K. and Swedish scientists, and the intellectual interplay between them that led to the award of a joint Nobel Prize half a century after the first discovery of these astonishingly versatile mediators. Expand
Adventures in vascular biology: a tale of two mediators
  • S. Moncada
  • History, Medicine
  • Philosophical Transactions of the Royal Society B: Biological Sciences
  • 2006
TLDR
The discovery of two substances, prostacyclin and nitric oxide, and the moments of insight and some of the critical experiments that contributed significantly to the uncovering of their roles in vascular biology are described. Expand
The release and fate of vaso‐active hormones in the circulation
  • J. Vane
  • Chemistry, Medicine
  • British journal of pharmacology
  • 1969
Some of Gaddum's first publications were on the development of specific and sensitive methods for biological assay, and he maintained a deep interest in this subject for the rest of his life (seeExpand
The discovery of nitric oxide and its role in vascular biology
TLDR
The role of NO in the cardiovascular system where, in addition to maintaining a vasodilator tone, it inhibits platelet aggregation and adhesion and modulates smooth muscle cell proliferation is focused on. Expand
Sir John Robert Vane (1927–2004)
TLDR
Sir John Vane invented the Vane's bioas-say cascade, a new way to tease the Nature with subversive questions, and brought an end to the romantic, stimulating era in history of experimental medicine. Expand
The inflammatory response to cardiopulmonary bypass: part 1--mechanisms of pathogenesis.
TLDR
What was once a perilous, experimental procedure has been transformed into a relatively standard medical act, performed on more than half a million patients worldwide per year, because of a number of major factors. Expand
The renin-angiotensin system: going beyond the classical paradigms
TLDR
This review summarizes the presentations given at the International Union of Physiological Sciences Congress in Rio de Janeiro, Brazil, in 2017, during the symposium entitled “The Renin-Angiotensin System: Going Beyond the Classical Paradigms,” in which the signaling and physiological actions of ANG-(1−7), ACE2, AT2R, and alatensins were reported (with a focus on noncentral nervous system-related tissues). Expand
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes
TLDR
Enzymes are one of the six major pharmacological targets into which the Concise Guide is divided, with the others being: G protein‐coupled receptors, ion channels, nuclear hormone receptors, catalytic receptors and transporters. Expand
The pulmonary uptake, accumulation, and metabolism of xenobiotics.
TLDR
One important function of lung is to regulate the systemic concentration of biologically active endogenous compounds by selective removal or metabo­ lism, and certain polypeptides in venous blood are handled in this manner. Expand
...
1
2
3
4
5
...